CVE-2006-5063
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject...
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject arbitrary web script or HTML by editing log entries in HTML mode.
Exploit likelihood
What each source reports
NVD Score used
5.1
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject arbitrary web script or HTML by editing log entries in HTML mode.
- Record
CVE-2006-5063- CVSS 2.0
- 5.1 Medium
AV:N/AC:H/Au:N/C:P/I:P/A:P - Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject arbitrary web script or HTML by editing log entries in HTML mode.
- Record
CVE-2006-5063- Updated
- 2026-11-02
EUVDEUVD-2006-5048 No score
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject arbitrary web script or HTML by editing log entries in HTML mode.
- Record
EUVD-2006-5048- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-gw8f-chrw-2547 No score
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject...
Cross-site scripting (XSS) vulnerability in Elog 2.6.1 allows remote attackers to inject arbitrary web script or HTML by editing log entries in HTML mode.
- Record
GHSA-gw8f-chrw-2547- Updated
- 2026-11-02
Affected products
Affected packages
| Package | Affected | Fixed |
|---|---|---|
elogDebian:3.1 From an advisory covering 4 CVEs |
before 2.5.7+r1558-4+sarge3, plus listed versions 2.5.7+r1558-32.5.7+r1558-4+sarge12.5.7+r1558-4+sarge2 |
2.5.7+r1558-4+sarge3 |
History
| Recorded | Changed | Sources |
|---|---|---|
| affected, facts | ||
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2006-5063 is a medium vulnerability (CVSS 5.1) in Stefan Ritt Elog Web Logbook, published September 28, 2006. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.43%, the 73rd percentile. No source names a fixed version.